Letters: Rserpine and prostatic cancer.
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002471:Cell Transformation, Neoplastic / Q000188:drug therapy*; D003911:Dextrans / Q000494:pharmacology; D004341:Drug Evaluation; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D008297:Male; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology* / Q000627:therapeutic use
D003911:Dextrans; D006634:Histamine H1 Antagonists; D006632:Histamine; D012110:Reserpine